Evaxion A (EVAX) Accounts Payables (2019 - 2025)

Evaxion A (EVAX) reported Accounts Payables of $2.2 million for Q4 2025, down 26.35% on a YoY basis from $3.0 million in Q4 2024, and down 12.42% quarter-over-quarter from $2.5 million in Q2 2025.

Evaxion A (EVAX) Accounts Payables (2019 - 2025) Analysis & Trends

Evaxion A has reported Accounts Payables for 7 years, with the latest figure at $2.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 26.35% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 26.35% YoY), and the FY2025 full-year result was $2.2 million, down 26.35% from the prior year.
  • Accounts Payables for Q4 2025 stood at $2.2 million, down from $2.5 million in the prior quarter.
  • The five-year high for Accounts Payables was $3.4 million in Q1 2021, with the low at $538000.0 in Q3 2021.
  • Historically, Accounts Payables has averaged $2.3 million across 5 years, with a median of $2.5 million in 2022.
  • Annual changes were most pronounced in 2022 — Accounts Payables surged 57.15% — and 2023, when it tumbled 30.91%.
  • Evaxion A's Accounts Payables stood at $2.8 million in 2021, then declined by 26.79% to $2.1 million in 2022, then rose by 28.97% to $2.7 million in 2023, then climbed by 10.38% to $3.0 million in 2024, then slipped by 26.35% to $2.2 million in 2025.
  • The last three Accounts Payables figures came in at $2.2 million (Q4 2025), $2.5 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.64 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.19 Mn
Jun 30, 2025 2.50 Mn
Dec 31, 2024 2.97 Mn
Jun 30, 2024 2.56 Mn
Dec 31, 2023 2.69 Mn
Jun 30, 2023 1.69 Mn
Dec 31, 2022 2.09 Mn
Jun 30, 2022 2.44 Mn
Mar 31, 2022 2.49 Mn
Dec 31, 2021 2.85 Mn
Sep 30, 2021 538,000.00
Jun 30, 2021 1.55 Mn
Mar 31, 2021 3.41 Mn
Dec 31, 2020 3.67 Mn
Dec 31, 2019 646,000.00